IP Verse

Editas Medicine, Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Editas Medicine, Inc. opposed by its competitors

Patent:
EP3129485
Grant Date:
Dec 21, 2022
Title:
Crispr/Cas-Related Methods And Compositions For Treating Cystic Fibrosis
Oppositions:
1
Patent:
EP3066201
Grant Date:
Mar 7, 2018
Title:
Crispr-Related Methods And Compositions With Governing Grnas
Oppositions:
2

Competitors of Editas Medicine, Inc.

JAMES POOLE LIMITED

GRUND, DR., MARTIN

Want to track Editas Medicine, Inc.?

Feel free to send us a message here and we will get back to you